Cargando…
Intravenous Zoledronate for a Patient with Paget's Disease
Paget's disease (PD) of bone is characterized by increase of bone resorption by atypical osteoclasts, followed by rapid new bone formation resulting in a disorganized mosaic bone. Although the pathophysiology is not fully understood, bisphosphonate, which is a potent anti-resorptive agent for t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society for Bone and Mineral Research
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170086/ https://www.ncbi.nlm.nih.gov/pubmed/25247161 http://dx.doi.org/10.11005/jbm.2014.21.3.223 |